cisapride and methylphenidate

cisapride has been researched along with methylphenidate in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Sharav, VH1

Other Studies

4 other study(ies) available for cisapride and methylphenidate

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
The impact of the Food and Drug Administration Modernization Act on the recruitment of children for research.
    Ethical human sciences and services : an international journal of critical inquiry, 2003,Summer, Volume: 5, Issue:2

    Topics: Adolescent; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Benzodiazepines; Child; Child, Preschool; Cisapride; Clinical Trials as Topic; Conflict of Interest; Drug Approval; Drug Industry; Humans; Infant; Legislation, Drug; Marketing; Methylphenidate; Nontherapeutic Human Experimentation; Olanzapine; Patient Selection; Psychotropic Drugs; Research Support as Topic; Risk Assessment; Schizophrenia; United States; United States Food and Drug Administration

2003